r3i Ventures is a woman founded early stage venture fund, dedicated to investing in women founders that disrupt and deliver impact. For example through its investments in StratifiCare, a company delivering the world’s first severe dengue prognostic to the global market. As a spinoff from the National University of Singapore, our Women Cofounders are working hard to improve patient outcomes, through delivering the right information at the right time, ensuring beds are made available only to those at risk severe dengue patients in need, and reducing the financial burden of unnecessary hospitalization by 67% on women and their families.